Does TRANDOLAPRIL\VERAPAMIL Cause Dermatitis exfoliative generalised? 8 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Dermatitis exfoliative generalised have been filed in association with TRANDOLAPRIL\VERAPAMIL. This represents 3.0% of all adverse event reports for TRANDOLAPRIL\VERAPAMIL.
8
Reports of Dermatitis exfoliative generalised with TRANDOLAPRIL\VERAPAMIL
3.0%
of all TRANDOLAPRIL\VERAPAMIL reports
0
Deaths
1
Hospitalizations
How Dangerous Is Dermatitis exfoliative generalised From TRANDOLAPRIL\VERAPAMIL?
Of the 8 reports, 1 (12.5%) required hospitalization, and 7 (87.5%) were considered life-threatening.
Is Dermatitis exfoliative generalised Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRANDOLAPRIL\VERAPAMIL. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does TRANDOLAPRIL\VERAPAMIL Cause?
Acute kidney injury (35)
Hypotension (35)
Cardiogenic shock (19)
Toxicity to various agents (19)
Bradycardia (18)
Condition aggravated (18)
Drug ineffective (15)
Dyspnoea (13)
Arterial disorder (12)
Dizziness (12)
What Other Drugs Cause Dermatitis exfoliative generalised?
ALLOPURINOL (192)
DUPILUMAB (162)
METHOTREXATE (151)
SULFAMETHOXAZOLE\TRIMETHOPRIM (140)
AMOXICILLIN (122)
ADALIMUMAB (113)
PANTOPRAZOLE (105)
SECUKINUMAB (96)
VANCOMYCIN (92)
AMLODIPINE (91)
Which TRANDOLAPRIL\VERAPAMIL Alternatives Have Lower Dermatitis exfoliative generalised Risk?
TRANDOLAPRIL\VERAPAMIL vs TRANEXAMIC ACID
TRANDOLAPRIL\VERAPAMIL vs TRANYLCYPROMINE
TRANDOLAPRIL\VERAPAMIL vs TRASTUZUMAB
TRANDOLAPRIL\VERAPAMIL vs TRASTUZUMAB-ANNS
TRANDOLAPRIL\VERAPAMIL vs TRASTUZUMAB DERUXTECAN